A Phase 1, Open-label, Randomized, Crossover Design Clinical Trial in Healthy Normal Volunteers to Evaluate Insulin Exposure and Effect Following Inhalation of Technosphere(R) Insulin Inhalation Powder at Multiple Doses Using the Gen2C Inhaler.
Phase of Trial: Phase I
Latest Information Update: 14 Jun 2016
At a glance
- Drugs Insulin (Primary) ; Insulin
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors MannKind Corporation
- 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
- 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 May 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.